NDC 76014-003

Bloxiverz

Neostigmine Methylsulfate

Bloxiverz is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Avadel Legacy Pharmaceuticals, Llc. The primary component is Neostigmine Methylsulfate.

Product ID76014-003_68ac2731-d4be-42a9-a418-e8507853ccc6
NDC76014-003
Product TypeHuman Prescription Drug
Proprietary NameBloxiverz
Generic NameNeostigmine Methylsulfate
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2013-07-24
Marketing End Date2023-05-31
Marketing CategoryNDA / NDA
Application NumberNDA204078
Labeler NameAvadel Legacy Pharmaceuticals, LLC
Substance NameNEOSTIGMINE METHYLSULFATE
Active Ingredient Strength1 mg/mL
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 76014-003-10

10 CARTON in 1 PACKAGE (76014-003-10) > 1 VIAL, MULTI-DOSE in 1 CARTON (76014-003-33) > 10 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2013-07-24
Marketing End Date2023-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 76014-003-33 [76014000333]

Bloxiverz INJECTION
Marketing CategoryNDA
Application NumberNDA204078
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-07-24

NDC 76014-003-10 [76014000310]

Bloxiverz INJECTION
Marketing CategoryNDA
Application NumberNDA204078
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-07-24

Drug Details

Active Ingredients

IngredientStrength
NEOSTIGMINE METHYLSULFATE1 mg/mL

OpenFDA Data

SPL SET ID:79ee2111-d65c-11e1-9b23-0800200c9a66
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1429282
  • 311935
  • 1429284
  • 311936
    • UPC Code
  • 0376014002331
  • 0376014003338
  • 0376014003109
  • 0376014002102

    • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]
    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    NDC Crossover Matching brand name "Bloxiverz" or generic name "Neostigmine Methylsulfate"

    NDCBrand NameGeneric Name
    51754-1210BloxiverzNeostigmine Methylsulfate
    51754-1220BloxiverzNeostigmine Methylsulfate
    51754-1240Bloxiverzneostigmine methylsulfate
    68001-329BloxiverzBloxiverz
    76014-002BloxiverzBloxiverz
    76014-902BloxiverzBloxiverz
    76014-003BloxiverzBloxiverz
    76014-903BloxiverzBloxiverz
    0404-9925NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
    0517-1133Neostigmine MethylsulfateNeostigmine Methylsulfate
    0517-1134Neostigmine MethylsulfateNeostigmine Methylsulfate
    0548-9601NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
    0548-9602NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
    0641-6149Neostigmine MethylsulfateNeostigmine Methylsulfate
    0641-6150Neostigmine MethylsulfateNeostigmine Methylsulfate
    0641-6240Neostigmine MethylsulfateNeostigmine Methylsulfate
    14445-413NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
    14445-414NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
    23155-517Neostigmine MethylsulfateNeostigmine Methylsulfate
    23155-518Neostigmine MethylsulfateNeostigmine Methylsulfate
    25021-610Neostigmine MethylsulfateNeostigmine Methylsulfate
    25021-611Neostigmine MethylsulfateNeostigmine Methylsulfate
    31722-994neostigmine methylsulfateneostigmine methylsulfate
    31722-995neostigmine methylsulfateneostigmine methylsulfate
    42023-188NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
    42023-189NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
    43598-945Neostigmine MethylsulfateNeostigmine Methylsulfate
    50090-4532NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate
    50090-5197Neostigmine methylsulfateNeostigmine methylsulfate
    51662-1557NEOSTIGMINE METHYLSULFATENEOSTIGMINE METHYLSULFATE
    52584-057NEOSTIGMINE METHYLSULFATEneostigmine methylsulfate

    Trademark Results [Bloxiverz]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BLOXIVERZ
    BLOXIVERZ
    85686242 4433582 Live/Registered
    Éclat Pharmaceuticals, LLC
    2012-07-25
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.